Success Metrics

Clinical Success Rate
94.7%

Based on 18 completed trials

Completion Rate
95%(18/19)
Active Trials
6(21%)
Results Posted
56%(10 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_4
5
17%
Ph early_phase_1
1
3%
Ph not_applicable
16
55%
Ph phase_1
3
10%
Ph phase_3
2
7%
Ph phase_2
2
7%

Phase Distribution

4

Early Stage

2

Mid Stage

7

Late Stage

Phase Distribution29 total trials
Early Phase 1First-in-human
1(3.4%)
Phase 1Safety & dosage
3(10.3%)
Phase 2Efficacy & side effects
2(6.9%)
Phase 3Large-scale testing
2(6.9%)
Phase 4Post-market surveillance
5(17.2%)
N/ANon-phased studies
16(55.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.7%

18 of 19 finished

Non-Completion Rate

5.3%

1 ended early

Currently Active

6

trials recruiting

Total Trials

29

all time

Status Distribution
Active(8)
Completed(18)
Terminated(1)
Other(2)

Detailed Status

Completed18
Recruiting5
unknown2
Enrolling by invitation1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
29
Active
6
Success Rate
94.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (3.4%)
Phase 13 (10.3%)
Phase 22 (6.9%)
Phase 32 (6.9%)
Phase 45 (17.2%)
N/A16 (55.2%)

Trials by Status

completed1862%
enrolling_by_invitation13%
not_yet_recruiting13%
recruiting517%
terminated13%
unknown27%
active_not_recruiting13%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT04899492Not Applicable

Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy

Terminated
NCT07694492Not Applicable

Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid

Not Yet Recruiting
NCT07007195Early Phase 1

Smart Olfaction App to Reduce Relapse

Recruiting
NCT06169813Phase 1

E-cigarette Harm Reduction Among PLWHA in South Africa

Completed
NCT06948058Not Applicable

Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy

Recruiting
NCT06127589Not Applicable

The "Quit-for-Kids" Project: to Increase Abstinence and Protect Children From Tobacco Smoke Exposure

Recruiting
NCT03249428Not Applicable

Cytisine vs Nicotine Replacement Therapy

Enrolling By Invitation
NCT04525755Phase 1

STARS (Smoking Treatment And Remote Sampling) Study

Completed
NCT03315910Phase 4

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Active Not Recruiting
NCT07148232Phase 4

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness

Recruiting
NCT05815199Not Applicable

E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness

Recruiting
NCT01943994Not Applicable

Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study

Completed
NCT04045964Phase 4

Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families

Completed
NCT04126135Phase 4

Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy

Completed
NCT04465318Not Applicable

Electronic Cigarettes as a Harm Reduction Strategy Among Patients With COPD

Completed
NCT03673228Not Applicable

Preventing Smoking Relapse After Total Joint Replacement Surgery

Completed
NCT03982576Not Applicable

Innovations to Prevent Relapse Among Low-income African American Smokers

Completed
NCT03187730Phase 4

Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants

Completed
NCT02896400Phase 3

Optimizing Tobacco Dependence Treatment in the Emergency Department

Completed
NCT01008748Not Applicable

Determinants of Smoking Cessation Among Latinos

Completed

Drug Details

Intervention Type
DRUG
Total Trials
29